UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 109, 2014

GENOSYS, INC.

(Exact Name of Registrant as Specified in Charter)

Utah	000-49817	87-0671592
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. ~~Employer~~EmployerIdentification ~~Identification~~ No.)

5314 North 250 West, Suite 350

Provo, Utah 84604

(Address of Principal Executive Offices)

____________________

(801) 319-2324

(Registrant’s telephone number, including area code)

____________________

167 South Orem Boulevard

Orem, Utah 84058

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14.a-12)

[ ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 51.0201 ~~Departure~~Entry ofinto ~~Directors~~a orMaterial ~~Certain~~Definitive ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Agreement.

~~Effective~~On ~~as of~~ July 109, 2014, ~~GeNOsys~~Health Innovations, Inc. (~~the~~ “~~Company~~Health Innovations”), a wholly owned subsidiary of GeNOsys, Inc., entered into a ~~Consulting~~Manufacturing License Agreement (the “Agreement”) with ~~CFO~~Canyon ~~Advantage~~Ridge ~~Consulting~~Resources, LCLLC, d/b/a TransAmerican Medical Imaging (“~~CFO Advantage~~TransAmerican”), pursuant to which ~~CFO~~Health ~~Advantage~~Innovations ~~will~~licensed ~~provide~~to ~~accounting~~TransAmerican ~~and~~certain ~~related~~rights ~~financial~~to ~~services~~manufacture toHealth ~~the~~Innovations’ ~~Company.~~Nitric ~~CFO~~Oxide ~~Advantage~~Analyzer ~~will~~(the be“NOA”) ~~paid~~in asagreed anfields ~~independent~~of ~~contractor~~use. Under the terms of the ~~Consulting~~ Agreement, ~~CFO~~the ~~Advantage~~parties will beshare ~~paid~~equally ~~discounted~~the ~~hourly~~net ~~fees~~profits ~~ranging~~ from ~~$35~~the ~~per~~sales ~~hour~~proceeds of the NOA. Subject to ~~$145~~early ~~per~~termination ~~hour~~rights ~~for~~set ~~various~~forth ~~bookkeeping~~in the Agreement, ~~controller~~the term of the Agreement and ~~chief~~the ~~financial~~license ~~officer~~granted ~~type~~therein ~~services~~commenced on July 9, ~~depending~~2014 and shall continue in renewable five year increments ending on the ~~needs~~date of the ~~Company~~expiration ~~and~~of the ~~CFO~~last ~~Advantage~~of ~~employee~~the ~~performing~~issued ~~the~~or ~~services. CFO~~granted ~~Advantage~~patents ~~will~~to ~~provide~~expire included in the ~~chief~~patents ~~financial~~licensed ~~officer~~under ~~services~~the ~~until~~Agreement related to the ~~Company~~NOA. ~~becomes~~The ~~current~~Agreement onautomatically ~~its~~renews ~~periodic~~at ~~reporting~~the ~~obligations~~end ~~and~~of ~~thereafter~~each ~~until~~term unless either party notifies the ~~Company~~other ~~completes~~in ~~its~~writing ~~search~~at ~~for~~least a120 ~~permanent~~days ~~Chief~~prior ~~Financial~~to ~~Officer~~the expiration of such term. The Agreement also contains customary warranties, indemnities and provisions regarding intellectual property ownership.

~~Robbie~~The ~~Chidester,~~foregoing ~~CPA,~~is ~~founded~~only ~~CFO~~a ~~Advantage~~brief indescription ~~2008.~~of Asthe ~~managing~~material ~~member~~terms of ~~CFO~~the ~~Advantage~~Agreement, ~~Mr.~~does ~~Chidester~~not ~~provides~~purport ~~outsourced accounting, financial management and advisory services~~ to ~~various~~be ~~clients. He has provided financial services to~~ a ~~vast~~complete ~~array~~description of ~~clients, including successful companies in~~ the ~~bio~~rights ~~technology, healthcare~~ and ~~manufacturing.~~obligations ~~Mr.~~of ~~Chidester~~the ~~has~~parties ~~spent~~thereunder ~~over 20 years as VP Finance, Chief Financial Officer, Board Member~~ and ~~Advisor.~~is ~~Working~~qualified ~~the~~in ~~past~~its ~~eight~~entirety ~~years~~by asreference ~~an outsourced or interim financial officer, he has provided financial management and advisory services~~ to ~~over~~the 20full ~~emerging~~text ~~businesses.~~of ~~He has personally assisted in~~ the ~~placement of over $335M in debt and equity funding~~Agreement. ~~Mr.~~ ~~Chidester~~A ~~began~~copy ~~his~~of ~~career in 1981 with~~ the ~~international~~Agreement ~~audit,~~is ~~tax~~attached ~~and~~as ~~advisory~~hereto ~~firm~~as ~~KPMG~~Exhibit ~~LLP~~10.1 Heand is aincorporated ~~licensed~~herein ~~Certified~~by ~~Public~~this ~~Accountant~~reference. ~~Mr. Chidester received a Bachelor’s Degree in Accounting, with honors, from the University of Utah.~~

~~SIGNATURES~~Item 9.01 - Financial Statements, Pro Forma Financial Information and Exhibits.

~~Pursuant~~(d) ~~to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~Exhibits:

~~Date: July~~Exhibit ~~16, 2014~~10.1

~~GENOSYS~~Manufacturing License Agreement, ~~INC~~dated July 9, 2014, between Health Innovations, Inc. and Canyon Ridge Resources, LLC, d/b/a TransAmerican Medical Imaging.

~~By:~~ SIGNATURES

~~/s/~~Pursuant ~~John~~to W.the R.requirements ~~Miller~~of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~Name~~Date: ~~John~~August W.21, ~~R. Miller~~2014

~~Its: Chief~~GENOSYS, ~~Executive Officer~~INC.

By:

/s/ John W. R. Miller

Name: John W. R. Miller

Its: Chief Executive Officer

Filing Compare · GeNOsys, Inc.